The FDA is the regulator - their job is to review all the evidence and provide the requirements - they get to decide. (there is a framework, but each drug getting approval is the first of its kind - otherwise, we wouldn't be here seeking approval) every product has its own specific requirements based on all the evidence that is given to the regulator. There are NO specific written rules just the framework.
e.g. how "prominent" some labelling needs to be would be specific to each product's safety profile. - again I highlight that "prominent" is subjective and is decided by the regulator.
You talk like you can "appeal" a regulator - indeed you can but often (you would be wasting your time as the decision would still be) we have already told you what we have decided appeals are very expensive processes and you would have to have a very strong case taking the FDA through the court and legal system - the real question is why would you appeal over just doing the small thing that they asked for. - be happy that they didn't ask for 3 more trials and for the trials to be each 3 years long.
- Forums
- ASX - By Stock
- BOT
- Ann: Presentation- FDA Letter Requires Patient Instruction Update
Ann: Presentation- FDA Letter Requires Patient Instruction Update, page-57
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
37.5¢ |
Change
0.005(1.35%) |
Mkt cap ! $678.7M |
Open | High | Low | Value | Volume |
37.0¢ | 38.0¢ | 36.5¢ | $762.9K | 2.048M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
29 | 322035 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 114951 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
28 | 320133 | 0.370 |
10 | 279140 | 0.365 |
10 | 502187 | 0.360 |
8 | 167011 | 0.355 |
8 | 518350 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 119328 | 4 |
0.380 | 934757 | 19 |
0.385 | 238502 | 8 |
0.390 | 373662 | 21 |
0.395 | 378120 | 10 |
Last trade - 13.49pm 15/08/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online